ABBV AbbVie Inc

By Matt Grossman

AbbVie Inc. on Friday raised its full-year earnings guidance after posting strong year-over-year revenue growth in the first quarter.

The Chicago-based pharmaceutical company said it now expects full-year adjusted earnings of $12.37 a share to $12.57 a share. Previously, it had forecast full-year adjusted earnings of $12.32 a share to $12.52 a share.

Analysts surveyed by FactSet had been forecasting full-year adjusted earnings of $12.39 a share.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

April 30, 2021 08:12 ET (12:12 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.